Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Roche talks up Phase 3 success rate as it unveils pipeline cuts

Where other European pharmas — notably Novartis, Novo and AstraZeneca — have suffered huge late-stage clinical failures this summer, Roche is feeling rather smug. CEO Thomas Schinecker said ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 22 October →